Sun Pharma Slumps 3% Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the ...
Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility as 'official action indicated' (OAI), indicating recommended regulatory or administrative actions.
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 1,870 in its research report dated April 23, 2024. Dadra's specialization lies in the ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483, with five observations, from the US ...
Sun Grid, unveiled seven weeks ago, has been one of the most visible software-as-a-service initiatives from new Sun CEO Jonathan Schwartz. In fact, Schwartz touts Sun Grid as the only public ...
(KFVS) - There is a chance for scattered storms in some places this morning and into the afternoon, but we are tracking a stronger possibility for severe weather Sunday night. After some ...
The weather slowly improves Sunday as a pesky low off New England moves to the east. Expect a mix of sun and clouds this afternoon, with more clouds the farther east of New York City you go.